Search Results - "Hirsch, H.H"

Refine Results
  1. 1

    European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011) by Matthes-Martin, S., Feuchtinger, T., Shaw, P.J., Engelhard, D., Hirsch, H.H., Cordonnier, C., Ljungman, P.

    Published in Transplant infectious disease (01-12-2012)
    “…Human adenovirus (HAdV) infections are increasingly recognized as important pathogens in immunocompromised hosts, especially in patients with severely…”
    Get full text
    Journal Article
  2. 2

    BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP‐12 by Hirsch, H. H., Yakhontova, K., Lu, M., Manzetti, J.

    Published in American journal of transplantation (01-03-2016)
    “…BK polyomavirus (BKPyV) replication causes nephropathy and premature kidney transplant failure. Insufficient BKPyV‐specific T cell control is regarded as a key…”
    Get full text
    Journal Article
  3. 3

    Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients by San-Juan, R., Comoli, P., Caillard, S., Moulin, B., Hirsch, H.H, Meylan, P.

    Published in Clinical microbiology and infection (01-09-2014)
    “…Epstein-Barr virus (EBV) contributes to the pathogenesis of post-transplant lymphoproliferative disease (PTLD) in more than 70% of cases. EBV DNAemia…”
    Get full text
    Journal Article
  4. 4

    European perspective on human polyomavirus infection, replication and disease in solid organ transplantation by Hirsch, H.H, Babel, N., Comoli, P., Friman, V., Ginevri, F., Jardine, A., Lautenschlager, I., Legendre, C., Midtvedt, K., Muñoz, P., Randhawa, P., Rinaldo, C.H, Wieszek, A.

    Published in Clinical microbiology and infection (01-09-2014)
    “…Human polyomaviruses (HPyVs) are a growing challenge in immunocompromised patients in view of the increasing number of now 12 HPyV species and their diverse…”
    Get full text
    Journal Article
  5. 5

    Pathology of Resolving Polyomavirus‐Associated Nephropathy by Menter, T., Mayr, M., Schaub, S., Mihatsch, M. J., Hirsch, H. H., Hopfer, H.

    Published in American journal of transplantation (01-06-2013)
    “…Control of polyomavirus BK (BKV) is achieved by reducing immunosuppression allowing an effective BKV‐specific T‐cell response. The morphology of resolving…”
    Get full text
    Journal Article
  6. 6

    Prospective Monitoring of Polyomavirus BK Replication and Impact of Pre‐Emptive Intervention in Pediatric Kidney Recipients by Ginevri, F., Azzi, A., Hirsch, H. H., Basso, S., Fontana, I., Cioni, M., Bodaghi, S., Salotti, V., Rinieri, A., Botti, G., Perfumo, F., Locatelli, F., Comoli, P.

    Published in American journal of transplantation (01-12-2007)
    “…Polyoma BK virus (BKV)‐associated nephropathy (PVAN) is a relevant cause of poor renal allograft survival. In a prospective analysis, we monitored BKV DNA in…”
    Get full text
    Journal Article
  7. 7

    Polyomavirus BK Replication Dynamics In Vivo and In Silico to Predict Cytopathology and Viral Clearance in Kidney Transplants by Funk, G. A., Gosert, R., Comoli, P., Ginevri, F., Hirsch, H. H.

    Published in American journal of transplantation (01-11-2008)
    “…Fast BK virus (BKV) replication in renal tubular epithelial cells drives polyomavirus‐BK‐associated nephropathy (PVAN) to premature kidney transplant (KT)…”
    Get full text
    Journal Article
  8. 8

    Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells by Dirks, J., Egli, A., Sester, U., Sester, M., Hirsch, H.H.

    Published in Transplant infectious disease (01-02-2013)
    “…Background Programmed death receptor‐1 (PD‐1) compromises cytomegalovirus (CMV)‐specific T‐cell responses and has been linked to CMV viremia after…”
    Get full text
    Journal Article
  9. 9

    Polyomavirus-associated nephropathy: update on BK virus-specific immunity by Comoli, P., Binggeli, S., Ginevri, F., Hirsch, H.H.

    Published in Transplant infectious disease (01-06-2006)
    “…: The human polyomavirus type 1, also called BK virus (BKV), causes polyomavirus‐associated nephropathy (PVAN) in 1–10% of renal transplant recipients, with…”
    Get full text
    Journal Article
  10. 10

    Renal Failure Five Years After Lung Transplantation Due to Polyomavirus BK‐Associated Nephropathy by Egli, A., Helmersen, D. S., Taub, K., Hirsch, H. H., Johnson, A.

    Published in American journal of transplantation (01-10-2010)
    “…Polyomavirus‐associated nephropathy (PyVAN) is rare in nonrenal solid organ transplantation and only limited information is available from single cases. We…”
    Get full text
    Journal Article
  11. 11

    Diffuse gastrointestinal bleeding and BK polyomavirus replication in a pediatric allogeneic haematopoietic stem cell transplant patient by Koskenvuo, M, Lautenschlager, I, Kardas, P, Auvinen, E, Mannonen, L, Huttunen, P, Taskinen, M, Vettenranta, K, Hirsch, H.H

    Published in Journal of clinical virology (01-01-2015)
    “…Highlights • Gastrointestinal bleeding is a significant complication after allogeneic HSCT. • BKPyV viremia and gastrointestinal bleeding is reported in…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    BK Polyomavirus in Solid Organ Transplantation by Hirsch, H. H., Randhawa, P.

    Published in American journal of transplantation (01-03-2013)
    “…The human BK polyomavirus (BKV) is the major cause of polyomavirus‐associated nephropathy (PyVAN) putting 1–15% of kidney transplant patients at risk of…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20